"name","uid","code","short_name"
"Country or territory name","","country","country"
"ISO numeric country/territory code","","iso_numeric","iso_numeric"
"ISO 2-character country/territory code","","iso2","iso2"
"ISO 3-character country/territory code","","iso3","iso3"
"Case detection rate (all forms), percent","","c_cdr","c_cdr"
"Case detection rate (all forms), percent, high bound","","c_cdr_hi","c_cdr_hi"
"Case detection rate (all forms), percent, low bound","","c_cdr_lo","c_cdr_lo"
"Case notification rate, which is the total of new and relapse cases and cases with unknown previous TB treatment history per 100 000 population (calculated)","","c_newinc_100k","c_newinc_100k"
"Estimated incidence (all forms) per 100 000 population","","e_inc_100k","e_inc_100k"
"Estimated incidence (all forms) per 100 000 population, high bound","","e_inc_100k_hi","e_inc_100k_hi"
"Estimated incidence (all forms) per 100 000 population, low bound","","e_inc_100k_lo","e_inc_100k_lo"
"Estimated number of incident cases (all forms)","","e_inc_num","e_inc_num"
"Estimated number of incident cases (all forms), high bound","","e_inc_num_hi","e_inc_num_hi"
"Estimated number of incident cases (all forms), low bound","","e_inc_num_lo","e_inc_num_lo"
"Estimated incidence of TB cases who are HIV-positive per 100 000 population","","e_inc_tbhiv_100k","e_inc_tbhiv_100k"
"Estimated incidence of TB cases who are HIV-positive per 100 000 population, high bound","","e_inc_tbhiv_100k_hi","e_inc_tbhiv_100k_hi"
"Estimated incidence of TB cases who are HIV-positive per 100 000 population, low bound","","e_inc_tbhiv_100k_lo","e_inc_tbhiv_100k_lo"
"Estimated incidence of TB cases who are HIV-positive","","e_inc_tbhiv_num","e_inc_tbhiv_num"
"Estimated incidence of TB cases who are HIV-positive, high bound","","e_inc_tbhiv_num_hi","e_inc_tbhiv_num_hi"
"Estimated incidence of TB cases who are HIV-positive, low bound","","e_inc_tbhiv_num_lo","e_inc_tbhiv_num_lo"
"Estimated number of MDR-TB cases among all notified pulmonary TB cases","","e_mdr_num","e_mdr_num"
"Estimated number of MDR-TB cases among all notified pulmonary TB cases: high bound","","e_mdr_num_hi","e_mdr_num_hi"
"Estimated number of MDR-TB cases among all notified pulmonary TB cases: low bound","","e_mdr_num_lo","e_mdr_num_lo"
"Estimated mortality of TB cases (all forms, excluding HIV) per 100 000 population","","e_mort_exc_tbhiv_100k","e_mort_exc_tbhiv_100k"
"Estimated mortality of TB cases (all forms, excluding HIV), per 100 000 population, high bound","","e_mort_exc_tbhiv_100k_hi","e_mort_exc_tbhiv_100k_hi"
"Estimated mortality of TB cases (all forms, excluding HIV), per 100 000 population, low bound","","e_mort_exc_tbhiv_100k_lo","e_mort_exc_tbhiv_100k_lo"
"Estimated number of deaths from TB (all forms, excluding HIV)","","e_mort_exc_tbhiv_num","e_mort_exc_tbhiv_num"
"Estimated number of deaths from TB (all forms, excluding HIV), high bound","","e_mort_exc_tbhiv_num_hi","e_mort_exc_tbhiv_num_hi"
"Estimated number of deaths from TB (all forms, excluding HIV), low bound","","e_mort_exc_tbhiv_num_lo","e_mort_exc_tbhiv_num_lo"
"Estimated mortality of TB cases who are HIV-positive, per 100 000 population","","e_mort_tbhiv_100k","e_mort_tbhiv_100k"
"Estimated mortality of TB cases who are HIV-positive, per 100 000 population, high bound","","e_mort_tbhiv_100k_hi","e_mort_tbhiv_100k_hi"
"Estimated mortality of TB cases who are HIV-positive, per 100 000 population, low bound","","e_mort_tbhiv_100k_lo","e_mort_tbhiv_100k_lo"
"Estimated number of deaths from TB in people who are HIV-positive","","e_mort_tbhiv_num","e_mort_tbhiv_num"
"Estimated number of deaths from TB in people who are HIV-positive, high bound","","e_mort_tbhiv_num_hi","e_mort_tbhiv_num_hi"
"Estimated number of deaths from TB in people who are HIV-positive, low bound","","e_mort_tbhiv_num_lo","e_mort_tbhiv_num_lo"
"Estimated number of MDR-TB cases among notified new pulmonary TB cases","","e_new_mdr_num","e_new_mdr_num"
"Estimated number of MDR-TB cases among notified new pulmonary TB cases: high bound","","e_new_mdr_num_hi","e_new_mdr_num_hi"
"Estimated number of MDR-TB cases among notified new pulmonary TB cases: low bound","","e_new_mdr_num_lo","e_new_mdr_num_lo"
"Estimated percentage of new TB cases with MDR-TB","","e_new_mdr_pcnt","e_new_mdr_pcnt"
"Estimated percentage of new TB cases with MDR-TB: high bound","","e_new_mdr_pcnt_hi","e_new_mdr_pcnt_hi"
"Estimated percentage of new TB cases with MDR-TB: low bound","","e_new_mdr_pcnt_lo","e_new_mdr_pcnt_lo"
"Estimated total population number","","e_pop_num","e_pop_num"
"Estimated prevalence of TB (all forms) per 100 000 population","","e_prev_100k","e_prev_100k"
"Estimated prevalence of TB (all forms) per 100 000 population, high bound","","e_prev_100k_hi","e_prev_100k_hi"
"Estimated prevalence of TB (all forms) per 100 000 population, low bound","","e_prev_100k_lo","e_prev_100k_lo"
"Estimated prevalence of TB (all forms)","","e_prev_num","e_prev_num"
"Estimated prevalence of TB (all forms), high bound","","e_prev_num_hi","e_prev_num_hi"
"Estimated prevalence of TB (all forms), low bound","","e_prev_num_lo","e_prev_num_lo"
"Estimated number of MDR-TB cases among notified previously treated pulmonary TB cases","","e_ret_mdr_num","e_ret_mdr_num"
"Estimated number of MDR-TB cases among notified previously treated pulmonary TB cases: high bound","","e_ret_mdr_num_hi","e_ret_mdr_num_hi"
"Estimated number of MDR-TB cases among notified previously treated pulmonary TB cases: low bound","","e_ret_mdr_num_lo","e_ret_mdr_num_lo"
"Estimated percentage of previously treated TB cases with MDR-TB","","e_ret_mdr_pcnt","e_ret_mdr_pcnt"
"Estimated percentage of previously treated TB cases with MDR-TB: high bound","","e_ret_mdr_pcnt_hi","e_ret_mdr_pcnt_hi"
"Estimated percentage of previously treated TB cases with MDR-TB: low bound","","e_ret_mdr_pcnt_lo","e_ret_mdr_pcnt_lo"
"Estimated HIV in incident TB (percent)","","e_tbhiv_prct","e_tbhiv_prct"
"Estimated HIV in incident TB (percent), high bound","","e_tbhiv_prct_hi","e_tbhiv_prct_hi"
"Estimated HIV in incident TB (percent), low bound","","e_tbhiv_prct_lo","e_tbhiv_prct_lo"
"Indicates whether national or subnational data from drug resistance surveys or surveillance was used to estimate the proportion of new TB cases with MDR-TB","","source_drs_coverage_new","source_drs_coverage_new"
"Indicates whether national or subnational data from drug resistance surveys or surveillance was used to estimate the proportion of previously treated TB cases with MDR-TB","","source_drs_coverage_ret","source_drs_coverage_ret"
"Year of drug resistance surveillance, survey or model used to estimate proportion of new TB cases with MDR-TB","","source_drs_year_new","source_drs_year_new"
"Year of drug resistance surveillance, survey or model used to estimate proportion of previously treated TB cases with MDR-TB","","source_drs_year_ret","source_drs_year_ret"
"Method to derive incidence estimates","","source_inc","source_inc"
"Method used to estimate proportion of new TB patients with MDR-TB","","source_mdr_new","source_mdr_new"
"Method used to estimate proportion of previously-treated TB patients with MDR-TB","","source_mdr_ret","source_mdr_ret"
"Method to derive mortality estimates","","source_mort","source_mort"
"Method to derive prevalence estimates","","source_prev","source_prev"
"Method to derive TBHIV estimates","","source_tbhiv","source_tbhiv"
"Were any non-NTP laboratories in the private sector (including NGOs) collaborating with the NTP?","","collab_private_lab","collab_private_lab"
"Were any non-NTP laboratories in the public sector collaborating with the NTP?","","collab_public_lab","collab_public_lab"
"Number of laboratories providing TB diagnostic services using culture","","lab_cul","lab_cul"
"Number of laboratories providing TB diagnostic services using drug susceptibility testing","","lab_dst","lab_dst"
"Number of drug susceptibility testing laboratories for which External Quality Assessment (EQA) was carried out","","lab_dst_eqa","lab_dst_eqa"
"Number of drug susceptibility testing laboratories which demonstrated acceptable performance","","lab_dst_eqa_pass","lab_dst_eqa_pass"
"Number of laboratories providing TB diagnostic services using Line Probe Assay (LPA) rifampicin","","lab_lpa","lab_lpa"
"Number of Line Probe Assay (LPA) rifampicin  laboratories for which External Quality Assessment (EQA) was carried out","","lab_lpa_eqa","lab_lpa_eqa"
"Number of Line Probe Assay (LPA) rifampicin laboratories which demonstrated acceptable performance","","lab_lpa_eqa_pass","lab_lpa_eqa_pass"
"Number of laboratories providing TB diagnostic services using smear microscopy","","lab_sm","lab_sm"
"Number of smear microscopy laboratories for which External Quality Assessment (EQA) was carried out","","lab_sm_eqa","lab_sm_eqa"
"Number of smear microscopy laboratories which demonstrated acceptable performance","","lab_sm_eqa_pass","lab_sm_eqa_pass"
"Number of laboratories providing TB diagnostic services using LED microscopes for smear microscopy","","lab_sm_led","lab_sm_led"
"Number of laboratories providing TB diagnostic services using xpert MTB/RIF","","lab_xpert","lab_xpert"
"Number of laboratories providing TB diagnostic services using xpert MTB/RIF for which External Quality Assessment (EQA) was carried out","","lab_xpert_eqa","lab_xpert_eqa"
"Was there a national reference laboratory or laboratories (NRL)?","","nrl","nrl"
"Has a formal quality management system towards achieving laboratory accreditation been implemented at the National Reference Laboratory?","","nrl_qms","nrl_qms"
"Has a formal link been established between the National Reference Laboratory and a partner Supranational Reference Laboratory?","","nrl_srl_link","nrl_srl_link"
"Was second-line drug susceptibility testing available within the country for TB National Treatment Programme patients?","","sldst_avail_incntry","sldst_avail_incntry"
"Was second-line drug susceptibility testing available outside the country for TB National Treatment Programme patients?","","sldst_avail_outcntry","sldst_avail_outcntry"
"Lower limit (95% confidence interval) of prevalence (%) of HIV in TB patients estimated using sentinel sites","","tbhiv_sentin_cil","tbhiv_sentin_cil"
"Upper limit (95% confidence interval) of prevalence (%) of HIV in TB patients estimated using sentinel sites","","tbhiv_sentin_ciu","tbhiv_sentin_ciu"
"Prevalence (%) of HIV in TB patients estimated using sentinel sites","","tbhiv_sentin_prev","tbhiv_sentin_prev"
"Year in which prevalence of HIV in TB patients was estimated using sentinel sites","","tbhiv_sentin_yr","tbhiv_sentin_yr"
"Lower limit (95% confidence interval) of prevalence (%) of HIV in TB patients estimated using nationwide representative surveys","","tbhiv_surv_cil","tbhiv_surv_cil"
"Upper limit (95% confidence interval) of prevalence (%) of HIV in TB patients estimated using nationwide representative surveys","","tbhiv_surv_ciu","tbhiv_surv_ciu"
"Prevalence (%) of HIV in TB patients estimated using nationwide representative
surveys","","tbhiv_surv_prev","tbhiv_surv_prev"
"Year in which prevalence of HIV in TB patients was estimated using nationwide representative surveys","","tbhiv_surv_yr","tbhiv_surv_yr"
"Total of new and relapse cases and cases with unknown previous TB treatment history","","c_newinc","c_newinc"
"Number of laboratory-confirmed cases of rifampicin-resistant TB (RR-TB) or multidrug-resistant TB (MDR-TB) identified among all TB patients (pumonary or extrapulmonary; new, previously treated or unknown treatment history)","","c_rrmdr","c_rrmdr"
"Number of laboratory-confirmed MDR-TB patients who started treatment for MDR-TB","","conf_mdr_tx","conf_mdr_tx"
"Number of laboratory-confirmed rifampicin-resistant (RR-TB) or multidrug-resistant TB (MDR-TB) patients who started treatment for MDR-TB","","conf_rrmdr_tx","conf_rrmdr_tx"
"Number of laboratory-confirmed XDR-TB patients who started treatment for XDR-TB","","conf_xdr_tx","conf_xdr_tx"
"Drug resistance surveillance: Among new TB patients with positive identification for M. Tuberculosis complex (confirmed by culture and/or line-probe assay): number of patients with available drug susceptibility testing results for isoniazid and rifampicin","","dst_rlt_new","dst_rlt_new"
"Drug resistance surveillance: Among patients previously treated for TB with positive identification for M. Tuberculosis complex (confirmed by culture and/or line-probe assay): number of patients with available drug susceptibility testing results for isoniazid and rifampicin","","dst_rlt_ret","dst_rlt_ret"
"Drug resistance surveillance: Among patients with unknown TB treatment history with positive identification for M. Tuberculosis complex (confirmed by culture and/or line-probe assay): number of patients with available drug susceptibility testing results for isoniazid and rifampicin","","dst_rlt_unk","dst_rlt_unk"
"HIV-positive TB patients started or continued on antiretroviral therapy (ART)","","hiv_art","hiv_art"
"HIV-positive TB patients started or continued on co-trimoxazole preventive therapy (CPT)","","hiv_cpt","hiv_cpt"
"People registered as HIV-positive given isoniazid prophylaxis (treatment of latent TB infection)","","hiv_ipt","hiv_ipt"
"Total number of people registered as HIV-positive regardless of year of diagnosis. (Total number of adults and children enrolled in HIV care; includes everyone in the HIV care and/or ART register)","","hiv_reg","hiv_reg"
"Number of adults and children newly enrolled in HIV care during the year.","","hiv_reg_new","hiv_reg_new"
"Number of adults and children enrolled in HIV care who had their TB status assessed and recorded during their last visit","","hiv_tbscr","hiv_tbscr"
"TB patients (new and re-treatment) with an HIV test result recorded in the TB register","","hivtest","hivtest"
"TB patients (new and re-treatment) recorded as HIV-positive","","hivtest_pos","hivtest_pos"
"Number of laboratory-confirmed cases of multidrug-resistant TB (MDR-TB) identified among all TB patients (new, previously treated, or unknown treatment history)","","mdr","mdr"
"Drug resistance surveillance: Total number of MDR-TB patients with drug susceptibility test results for any fluoroquinolone and any second-line injectable agent","","mdr_dst_rlt","mdr_dst_rlt"
"Drug resistance surveillance: Among new TB patients with available drug susceptibility testing results (variable dst_rlt_new):  number of patients with resistance to isoniazid and rifampicin  (MDR-TB)","","mdr_new","mdr_new"
"Drug resistance surveillance: Among patients previously treated for TB with available drug susceptibility testing results (variable dst_rlt_ret):  number of patients with resistance to isoniazid and rifampicin  (MDR-TB)","","mdr_ret","mdr_ret"
"Drug resistance surveillance: Among patients with unknown TB treatment history with available drug susceptibility testing results (variable dst_rlt_unk):  number of patients with resistance to isoniazid and rifampicin  (MDR-TB)","","mdr_unk","mdr_unk"
"Number of patients started on Bedaquiline during the reporting year","","mdrxdr_bdq_tx","mdrxdr_bdq_tx"
"Had any TB patients been started on Bedaquiline for the treatment of MDR-/XDR-TB by the end of reporting year as part of expanded access, compassionate use or under normal programmatic use, whether in the public or private sector?","","mdrxdr_bdq_used","mdrxdr_bdq_used"
"New pulmonary clinically diagnosed TB cases (not bacteriologically confirmed as positive for TB, but diagnosed with active TB by a clinician or another medical practitioner who has decided to give the patient a full course of TB treatment).  It also includes pulmonary clinically diagnosed cases with unknown previous TB treatment history.","","new_clindx","new_clindx"
"New extrapulmonary cases (bacteriologically confirmed or clinically diagnosed). As of 2013 this also includes extrapulmonary cases with unknown previous TB treatment history.","","new_ep","new_ep"
"New extrapulmonary cases: females aged 0-14 years (not used after 2012)","","new_ep_f014","new_ep_f014"
"New extrapulmonary cases: females aged 0-4 years (not used after 2012)","","new_ep_f04","new_ep_f04"
"New extrapulmonary cases: females aged 15-24 years (not used after 2012)","","new_ep_f1524","new_ep_f1524"
"New extrapulmonary cases: females aged 15 years and over (not used after 2012)","","new_ep_f15plus","new_ep_f15plus"
"New extrapulmonary cases: females aged 25-34 years (not used after 2012)","","new_ep_f2534","new_ep_f2534"
"New extrapulmonary cases: females aged 35-44 years (not used after 2012)","","new_ep_f3544","new_ep_f3544"
"New extrapulmonary cases: females aged 45-54 years (not used after 2012)","","new_ep_f4554","new_ep_f4554"
"New extrapulmonary cases: females aged 5-14 years (not used after 2012)","","new_ep_f514","new_ep_f514"
"New extrapulmonary cases: females aged 55-64 years (not used after 2012)","","new_ep_f5564","new_ep_f5564"
"New extrapulmonary cases: females aged 65 years and over (not used after 2012)","","new_ep_f65","new_ep_f65"
"New extrapulmonary cases: females age unknown (not used after 2012)","","new_ep_fu","new_ep_fu"
"New extrapulmonary cases: males aged 0-14 years (not used after 2012)","","new_ep_m014","new_ep_m014"
"New extrapulmonary cases: males aged 0-4 years (not used after 2012)","","new_ep_m04","new_ep_m04"
"New extrapulmonary cases: males aged 15-24 years (not used after 2012)","","new_ep_m1524","new_ep_m1524"
"New extrapulmonary cases: males aged 15 years and over (not used after 2012)","","new_ep_m15plus","new_ep_m15plus"
"New extrapulmonary cases: males aged 25-34 years (not used after 2012)","","new_ep_m2534","new_ep_m2534"
"New extrapulmonary cases: males aged 35-44 years (not used after 2012)","","new_ep_m3544","new_ep_m3544"
"New extrapulmonary cases: males aged 45-54 years (not used after 2012)","","new_ep_m4554","new_ep_m4554"
"New extrapulmonary cases: males aged 5-14 years (not used after 2012)","","new_ep_m514","new_ep_m514"
"New extrapulmonary cases: males aged 55-64 years (not used after 2012)","","new_ep_m5564","new_ep_m5564"
"New extrapulmonary cases: males aged 65 years and over (not used after 2012)","","new_ep_m65","new_ep_m65"
"New extrapulmonary cases: males age unknown (not used after 2012)","","new_ep_mu","new_ep_mu"
"New extrapulmonary cases: sex unknown, aged 0-14 years (not used after 2012)","","new_ep_sexunk014","new_ep_sexunk014"
"New extrapulmonary cases: sex unknown, aged 0-4 years (not used after 2012)","","new_ep_sexunk04","new_ep_sexunk04"
"New extrapulmonary cases: sex unknown, aged 15 years and over (not used after 2012)","","new_ep_sexunk15plus","new_ep_sexunk15plus"
"New extrapulmonary cases: sex unknown, aged 5-14 years (not used after 2012)","","new_ep_sexunk514","new_ep_sexunk514"
"New extrapulmonary cases: sex unknown, age unknown (not used after 2012)","","new_ep_sexunkageunk","new_ep_sexunkageunk"
"New and re-treatment TB cases among foreign-born individuals","","new_foreign","new_foreign"
"New pulmonary bacteriologically confirmed TB cases (smear positive or culture positive or positive by WHO-recommended rapid diagnostics such as Xpert MTB/RIF). As of 2013 this also includes pulmonary bacteriologically confirmed cases with unknown previous TB treatment history.","","new_labconf","new_labconf"
"Other new cases (not used after 2012)","","new_oth","new_oth"
"New pulmonary smear-negative cases (not used after 2012)","","new_sn","new_sn"
"New pulmonary smear negative/smear unknown/smear not done cases: females aged 0-14 years (not used after 2012)","","new_sn_f014","new_sn_f014"
"New pulmonary smear negative/smear unknown/smear not done cases: females aged 0-4 years (not used after 2012)","","new_sn_f04","new_sn_f04"
"New pulmonary smear negative/smear unknown/smear not done cases: females aged 15-24 years (not used after 2012)","","new_sn_f1524","new_sn_f1524"
"New pulmonary smear negative/smear unknown/smear not done cases: females aged 15 years and over (not used after 2012)","","new_sn_f15plus","new_sn_f15plus"
"New pulmonary smear negative/smear unknown/smear not done cases: females aged 25-34 years (not used after 2012)","","new_sn_f2534","new_sn_f2534"
"New pulmonary smear negative/smear unknown/smear not done cases: females aged 35-44 years (not used after 2012)","","new_sn_f3544","new_sn_f3544"
"New pulmonary smear negative/smear unknown/smear not done cases: females aged 45-54 years (not used after 2012)","","new_sn_f4554","new_sn_f4554"
"New pulmonary smear negative/smear unknown/smear not done cases: females aged 5-14 years (not used after 2012)","","new_sn_f514","new_sn_f514"
"New pulmonary smear negative/smear unknown/smear not done cases: females aged 55-64 years (not used after 2012)","","new_sn_f5564","new_sn_f5564"
"New pulmonary smear negative/smear unknown/smear not done cases: females aged 65 years and over (not used after 2012)","","new_sn_f65","new_sn_f65"
"New pulmonary smear negative/smear unknown/smear not done cases: females age unknown (not used after 2012)","","new_sn_fu","new_sn_fu"
"New pulmonary smear negative/smear unknown/smear not done cases: males aged 0-14 years (not used after 2012)","","new_sn_m014","new_sn_m014"
"New pulmonary smear negative/smear unknown/smear not done cases: males aged 0-4 years (not used after 2012)","","new_sn_m04","new_sn_m04"
"New pulmonary smear negative/smear unknown/smear not done cases: males aged 15-24 years (not used after 2012)","","new_sn_m1524","new_sn_m1524"
"New pulmonary smear negative/smear unknown/smear not done cases: males aged 15 years and above (not used after 2012)","","new_sn_m15plus","new_sn_m15plus"
"New pulmonary smear negative/smear unknown/smear not done cases: males aged 25-34 years (not used after 2012)","","new_sn_m2534","new_sn_m2534"
"New pulmonary smear negative/smear unknown/smear not done cases: males aged 35-44 years (not used after 2012)","","new_sn_m3544","new_sn_m3544"
"New pulmonary smear negative/smear unknown/smear not done cases: males aged 45-54 years (not used after 2012)","","new_sn_m4554","new_sn_m4554"
"New pulmonary smear negative/smear unknown/smear not done cases: males aged 5-14 years (not used after 2012)","","new_sn_m514","new_sn_m514"
"New pulmonary smear negative/smear unknown/smear not done cases: males aged 55-64 years (not used after 2012)","","new_sn_m5564","new_sn_m5564"
"New pulmonary smear negative/smear unknown/smear not done cases: males aged 65 years and over (not used after 2012)","","new_sn_m65","new_sn_m65"
"New pulmonary smear negative/smear unknown/smear not done cases: males age unknown (not used after 2012)","","new_sn_mu","new_sn_mu"
"New pulmonary smear negative/smear unknown/smear not done cases: sex unknown, aged 0-14 years (not used after 2012)","","new_sn_sexunk014","new_sn_sexunk014"
"New pulmonary smear negative/smear unknown/smear not done cases: sex unknown, aged 0-4 years (not used after 2012)","","new_sn_sexunk04","new_sn_sexunk04"
"New pulmonary smear negative/smear unknown/smear not done cases: sex unknown, aged 15 years and over (not used after 2012)","","new_sn_sexunk15plus","new_sn_sexunk15plus"
"New pulmonary smear negative/smear unknown/smear not done cases: sex unknown, aged 5-14 years (not used after 2012)","","new_sn_sexunk514","new_sn_sexunk514"
"New pulmonary smear negative/smear unknown/smear not done cases: sex unknown, age unknown (not used after 2012)","","new_sn_sexunkageunk","new_sn_sexunkageunk"
"New pulmonary smear-positive cases (not used after 2012)","","new_sp","new_sp"
"New pulmonary smear positive cases: females aged 0-14 years (not used after 2012)","","new_sp_f014","new_sp_f014"
"New pulmonary smear positive cases: females aged 0-4 years (not used after 2012)","","new_sp_f04","new_sp_f04"
"New pulmonary smear positive cases: females aged 15-24 years (not used after 2012)","","new_sp_f1524","new_sp_f1524"
"New pulmonary smear positive cases: females aged 25-34 years (not used after 2012)","","new_sp_f2534","new_sp_f2534"
"New pulmonary smear positive cases: females aged 35-44 years (not used after 2012)","","new_sp_f3544","new_sp_f3544"
"New pulmonary smear positive cases: females aged 45-54 years (not used after 2012)","","new_sp_f4554","new_sp_f4554"
"New pulmonary smear positive cases: females aged 5-14 years (not used after 2012)","","new_sp_f514","new_sp_f514"
"New pulmonary smear positive cases: females aged 55-64 years (not used after 2012)","","new_sp_f5564","new_sp_f5564"
"New pulmonary smear positive cases: females aged 65 and over (not used after 2012)","","new_sp_f65","new_sp_f65"
"New pulmonary smear positive cases: females age unknown (not used after 2012)","","new_sp_fu","new_sp_fu"
"New pulmonary smear positive cases: males aged 0-14 years (not used after 2012)","","new_sp_m014","new_sp_m014"
"New pulmonary smear positive cases: males aged 0-4 years (not used after 2012)","","new_sp_m04","new_sp_m04"
"New pulmonary smear positive cases: males aged 15-24 years (not used after 2012)","","new_sp_m1524","new_sp_m1524"
"New pulmonary smear positive cases: males aged 25-34 years (not used after 2012)","","new_sp_m2534","new_sp_m2534"
"New pulmonary smear positive cases: males aged 35-44 years (not used after 2012)","","new_sp_m3544","new_sp_m3544"
"New pulmonary smear positive cases: males aged 45-54 years (not used after 2012)","","new_sp_m4554","new_sp_m4554"
"New pulmonary smear positive cases: males aged 5-14 years (not used after 2012)","","new_sp_m514","new_sp_m514"
"New pulmonary smear positive cases: males aged 55-64 years (not used after 2012)","","new_sp_m5564","new_sp_m5564"
"New pulmonary smear positive cases: males aged 65 years and over (not used after 2012)","","new_sp_m65","new_sp_m65"
"New pulmonary smear positive cases: males age unknown (not used after 2012)","","new_sp_mu","new_sp_mu"
"New pulmonary smear unknown/not done cases","","new_su","new_su"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 0-14 years","","newrel_f014","newrel_f014"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 0-4 years","","newrel_f04","newrel_f04"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 15-24 years","","newrel_f1524","newrel_f1524"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 15 years and over","","newrel_f15plus","newrel_f15plus"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 25-34 years","","newrel_f2534","newrel_f2534"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 35-44 years","","newrel_f3544","newrel_f3544"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 45-54 years","","newrel_f4554","newrel_f4554"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 5-14 years","","newrel_f514","newrel_f514"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 55-64 years","","newrel_f5564","newrel_f5564"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females aged 65 years and over","","newrel_f65","newrel_f65"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): females age unknown","","newrel_fu","newrel_fu"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 0-14 years","","newrel_m014","newrel_m014"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 0-4 years","","newrel_m04","newrel_m04"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 15-24 years","","newrel_m1524","newrel_m1524"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 15 years and over","","newrel_m15plus","newrel_m15plus"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 25-34 years","","newrel_m2534","newrel_m2534"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 35-44 years","","newrel_m3544","newrel_m3544"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 45-54 years","","newrel_m4554","newrel_m4554"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 5-14 years","","newrel_m514","newrel_m514"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 55-64 years","","newrel_m5564","newrel_m5564"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males aged 65 years and over","","newrel_m65","newrel_m65"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): males age unknown","","newrel_mu","newrel_mu"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): sex unknown, aged 0-14 years","","newrel_sexunk014","newrel_sexunk014"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): sex unknown, aged 0-4 years","","newrel_sexunk04","newrel_sexunk04"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): sex unknown, aged 15 years and over","","newrel_sexunk15plus","newrel_sexunk15plus"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): sex unknown, aged 5-14 years","","newrel_sexunk514","newrel_sexunk514"
"New and relapse cases (but only new cases if rel_in_agesex_flg = 0): sex unknown, age unknown","","newrel_sexunkageunk","newrel_sexunkageunk"
"Other cases not included in new and re-treatment case numbers","","newret_oth","newret_oth"
"Number of TB cases (pulmonary or extrapulmonary) tested for susceptibility to rifampicin using phenotypic DST or WHO-recommended rapid molecular diagnostics (e.g. Xpert MTB/RIF), before or after starting treatment: new cases","","rdst_new","rdst_new"
"Number of TB cases (pulmonary or extrapulmonary) tested for susceptibility to rifampicin using phenotypic DST or WHO-recommended rapid molecular diagnostics (e.g. Xpert MTB/RIF), before or after starting treatment: previously treated cases","","rdst_ret","rdst_ret"
"Number of TB cases (pulmonary or extrapulmonary) tested for susceptibility to rifampicin using phenotypic DST or WHO-recommended rapid molecular diagnostics (e.g. Xpert MTB/RIF), before or after starting treatment: cases with unknown previous TB treatment history","","rdst_unk","rdst_unk"
"Are all relapse cases included with new cases in the disaggregations by age and sex?","","rel_in_agesex_flg","rel_in_agesex_flg"
"Previously treated patients, excluding relapse cases (pulmonary or extrapulmonary, bacteriologically confirmed or clinically diagnosed)","","ret_nrel","ret_nrel"
"Other re-treatment cases","","ret_oth","ret_oth"
"Relapse cases","","ret_rel","ret_rel"
"Relapse pulmonary clinically diagnosed TB cases (not bacteriologically confirmed as positive for TB, but diagnosed with active TB by a clinician or another medical practitioner who has decided to give the patient a full course of TB treatment).","","ret_rel_clindx","ret_rel_clindx"
"Relapse extrapulmonary cases (bacteriologically confirmed or clinically diagnosed)","","ret_rel_ep","ret_rel_ep"
"Relapse  pulmonary bacteriologically confirmed TB cases (smear positive or culture positive or positive by WHO-recommended rapid diagnostics such as Xpert MTB/RIF).","","ret_rel_labconf","ret_rel_labconf"
"Treatment after default cases","","ret_tad","ret_tad"
"Treatment after failure cases","","ret_taf","ret_taf"
"Number of MDR-TB (not laboratory-confirmed) patients who started treatment for MDR-TB","","unconf_mdr_tx","unconf_mdr_tx"
"Number of patients (not laboratory-confirmed as having rifampicin-resistant (RR-TB) or multidrg-resistant TB (MDR-TB)) who started treatment for MDR-TB","","unconf_rrmdr_tx","unconf_rrmdr_tx"
"Drug resistance surveillance: Among MDR-TB patients with drug susceptibility test results for any fluoroquinolone (FQ) and any second-line injectable agent (2LI) (variable mdr_dst_rlt): number with any resistance to both FQ and 2LI (i.e. XDR-TB)","","xdr","xdr"
"Among new pulmonary TB patients with positive identification for M. Tuberculosis complex confirmed by Xpert MTB/RIF alone and who are not confirmed by culture and/or line-probe assay: number with resistance to rifampicin","","xpert_dr_r_new","xpert_dr_r_new"
"Among previously treated pulmonary TB patients with positive identification for M. Tuberculosis complex confirmed by Xpert MTB/RIF alone and who are not confirmed by culture and/or line-probe assay: number with resistance to rifampicin","","xpert_dr_r_ret","xpert_dr_r_ret"
"Among pulmonary TB patients with unknown previous TB treatment history with positive identification for M. Tuberculosis complex confirmed by Xpert MTB/RIF alone and who are not confirmed by culture and/or line-probe assay: number with resistance to rifampicin","","xpert_dr_r_unk","xpert_dr_r_unk"
"Number of new pulmonary TB patients with positive identification for M. Tuberculosis complex confirmed by Xpert MTB/RIF alone and who are not confirmed by culture and/or line-probe assay","","xpert_new","xpert_new"
"Number of previously treated pulmonary TB patients with positive identification for M. Tuberculosis complex confirmed by Xpert MTB/RIF alone and who are not confirmed by culture and/or line-probe assay","","xpert_ret","xpert_ret"
"Number of pulmonary TB patients with unknown previous TB treatment history with positive identification for M. Tuberculosis complex confirmed by Xpert MTB/RIF alone and who are not confirmed by culture and/or line-probe assay","","xpert_unk","xpert_unk"
"Treatment success rate for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done cases, percent  (not used after 2011)","","c_new_snep_tsr","c_new_snep_tsr"
"Treatment success rate for new pulmonary smear-positive (and/or culture-positive) cases, percent  (not used after 2011)","","c_new_sp_tsr","c_new_sp_tsr"
"Treatment success rate for all new cases (including relapse cases if rel_with_new_flg = 1), percent","","c_new_tsr","c_new_tsr"
"Treatment success rate for re-treatment cases (excluding relapse cases if rel_with_new_flg = 1), percent","","c_ret_tsr","c_ret_tsr"
"Treatment success rate for HIV-positive TB cases, percent","","c_tbhiv_tsr","c_tbhiv_tsr"
"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done HIV-positive TB cases: completed  (not used after 2011)","","hiv_new_snep_cmplt","hiv_new_snep_cmplt"
"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done HIV-positive TB cases: cohort size  (not used after 2011)","","hiv_new_snep_coh","hiv_new_snep_coh"
"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done HIV-positive TB cases: defaulted  (not used after 2011)","","hiv_new_snep_def","hiv_new_snep_def"
"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done HIV-positive TB cases: died  (not used after 2011)","","hiv_new_snep_died","hiv_new_snep_died"
"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done HIV-positive TB cases: failed (not used after 2011)","","hiv_new_snep_fail","hiv_new_snep_fail"
"Outcomes for new pulmonary smear-positive (and/or culture-positive) HIV-positive TB cases: completed (not used after 2011)","","hiv_new_sp_cmplt","hiv_new_sp_cmplt"
"Outcomes for new pulmonary smear-positive (and/or culture-positive) HIV-positive TB cases: cohort size (not used after 2011)","","hiv_new_sp_coh","hiv_new_sp_coh"
"Outcomes for new pulmonary smear-positive (and/or culture-positive) HIV-positive TB cases: cured (not used after 2011)","","hiv_new_sp_cur","hiv_new_sp_cur"
"Outcomes for new pulmonary smear-positive (and/or culture-positive) HIV-positive TB cases: defaulted (not used after 2011)","","hiv_new_sp_def","hiv_new_sp_def"
"Outcomes for new pulmonary smear-positive (and/or culture-positive) HIV-positive TB cases: died (not used after 2011)","","hiv_new_sp_died","hiv_new_sp_died"
"Outcomes for new pulmonary smear-positive (and/or culture-positive) HIV-positive TB cases: failed (not used after 2011)","","hiv_new_sp_fail","hiv_new_sp_fail"
"Outcomes for re-treatment HIV-positive TB cases: completed (not used after 2011)","","hiv_ret_cmplt","hiv_ret_cmplt"
"Outcomes for re-treatment HIV-positive TB cases: cohort size (not used after 2011)","","hiv_ret_coh","hiv_ret_coh"
"Outcomes for re-treatment HIV-positive TB cases: cured (not used after 2011)","","hiv_ret_cur","hiv_ret_cur"
"Outcomes for re-treatment HIV-positive TB cases: defaulted (not used after 2011)","","hiv_ret_def","hiv_ret_def"
"Outcomes for re-treatment HIV-positive TB cases: died (not used after 2011)","","hiv_ret_died","hiv_ret_died"
"Outcomes for re-treatment HIV-positive TB cases: failed (not used after 2011)","","hiv_ret_fail","hiv_ret_fail"
"Outcomes for MDR-TB cases: cohort size","","mdr_coh","mdr_coh"
"Outcomes for MDR-TB cases: died","","mdr_died","mdr_died"
"Outcomes for MDR-TB cases: treatment failed","","mdr_fail","mdr_fail"
"Outcomes for MDR-TB cases: lost to follow-up","","mdr_lost","mdr_lost"
"Outcomes for MDR-TB cases: treatment success (Cured or treatment completed)","","mdr_succ","mdr_succ"
"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done cases: completed (not used after 2011)","","new_snep_cmplt","new_snep_cmplt"
"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done cases: cohort size (not used after 2011)","","new_snep_coh","new_snep_coh"
"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done cases: defauled (not used after 2011)","","new_snep_def","new_snep_def"
"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done cases: died (not used after 2011)","","new_snep_died","new_snep_died"
"Outcomes for new pulmonary smear-negative/extrapulmonary/smear unknown/smear not done cases: failed (not used after 2011)","","new_snep_fail","new_snep_fail"
"Outcomes for new pulmonary smear-positive (and/or culture-positive) cases: completed (not used after 2011)","","new_sp_cmplt","new_sp_cmplt"
"Outcomes for new pulmonary smear-positive (and/or culture-positive) cases: cohort size (not used after 2011)","","new_sp_coh","new_sp_coh"
"Outcomes for new pulmonary smear-positive (and/or culture-positive) cases: cured (not used after 2011)","","new_sp_cur","new_sp_cur"
"Outcomes for new pulmonary smear-positive (and/or culture-positive) cases: defaulted (not used after 2011)","","new_sp_def","new_sp_def"
"Outcomes for new pulmonary smear-positive (and/or culture-positive) cases: died (not used after 2011)","","new_sp_died","new_sp_died"
"Outcomes for new pulmonary smear-positive (and/or culture-positive) cases: failed (not used after 2011)","","new_sp_fail","new_sp_fail"
"Outcomes for all new and relapse cases (but only new cases if rel_with_new_flg = 0): cohort size","","newrel_coh","newrel_coh"
"Outcomes for all new and relapse cases (but only new cases if rel_with_new_flg = 0): died","","newrel_died","newrel_died"
"Outcomes for all new and relapse cases (but only new cases if rel_with_new_flg = 0): treatment failed","","newrel_fail","newrel_fail"
"Outcomes for all new and relapse cases (but only new cases if rel_with_new_flg = 0): lost to follow-up","","newrel_lost","newrel_lost"
"Outcomes for all new and relapse cases (but only new cases if rel_with_new_flg = 0): treatment success (cured or treatment completed)","","newrel_succ","newrel_succ"
"Are outcomes of relapse cases included in the newrel outcome variables?","","rel_with_new_flg","rel_with_new_flg"
"Method of confirmation used to report treatment outcomes of pulmonary cases  (not used after 2011)","","rep_meth","rep_meth"
"Outcomes for re-treatment cases: completed  (not used after 2011)","","ret_cmplt","ret_cmplt"
"Outcomes for re-treatment cases: cohort size (not used after 2011)","","ret_coh","ret_coh"
"Outcomes for re-treatment cases: cured (not used after 2011)","","ret_cur","ret_cur"
"Outcomes for re-treatment cases: defaulted (not used after 2011)","","ret_def","ret_def"
"Outcomes for re-treatment cases: died (not used after 2011)","","ret_died","ret_died"
"Outcomes for re-treatment cases: failed (not used after 2011)","","ret_fail","ret_fail"
"Outcomes for previously treated patients (excluding relapse cases if rel_with_new_flg = 1): cohort size","","ret_nrel_coh","ret_nrel_coh"
"Outcomes for previously treated patients (excluding relapse cases if rel_with_new_flg = 1): died","","ret_nrel_died","ret_nrel_died"
"Outcomes for previously treated patients (excluding relapse cases if rel_with_new_flg = 1): treatment failed","","ret_nrel_fail","ret_nrel_fail"
"Outcomes for previously treated patients (excluding relapse cases if rel_with_new_flg = 1): lost to follow-up","","ret_nrel_lost","ret_nrel_lost"
"Outcomes for previously treated patients (excluding relapse cases if rel_with_new_flg = 1): treatment success (cured or treatment completed)","","ret_nrel_succ","ret_nrel_succ"
"Outcomes for HIV-positive TB cases, all types: cohort size","","tbhiv_coh","tbhiv_coh"
"Outcomes for HIV-positive TB cases, all types: died","","tbhiv_died","tbhiv_died"
"Outcomes for HIV-positive TB cases, all types: treatment failed","","tbhiv_fail","tbhiv_fail"
"Outcomes for HIV-positive TB cases, all types: lost to follow-up","","tbhiv_lost","tbhiv_lost"
"Outcomes for HIV-positive TB cases, all types: treatment success (cured or treatment completed)","","tbhiv_succ","tbhiv_succ"
"Outcomes for XDR-TB cases: cohort size","","xdr_coh","xdr_coh"
"Outcomes for XDR-TB cases: number died","","xdr_died","xdr_died"
"Outcomes for XDR-TB cases: number whose treatment failed","","xdr_fail","xdr_fail"
"Outcomes for XDR-TB cases: lost to follow-up","","xdr_lost","xdr_lost"
"Outcomes for XDR-TB cases: treatment success (Cured or treatment completed)","","xdr_succ","xdr_succ"
"Did the National Treatment Programme keep (or have access to) an electronic case-based database for TB patients on treatment at national level","","caseb_err_nat","caseb_err_nat"
"Is there a component in the TB programme that provides palliative and end-of-life care to patients who have failed MDR-TB treatment or who have life-threatening sequelae of disease?","","eol_care","eol_care"
"Number of health-care workers who had TB","","hcw_tb_infected","hcw_tb_infected"
"Total number of health-care workers who were working in the country in the public and private sector","","hcw_tot","hcw_tot"
"Number of patients started on MDR-TB treatment by non-NTP providers in the reporting year","","mdr_tx_nonntp","mdr_tx_nonntp"
"Number of new cases of TB diagnosed according to National Treatment Programme (NTP)  guidelines by private providers","","priv_new_dx","priv_new_dx"
"Number of new cases of TB diagnosed according to National Treatment Programme (NTP)  guidelines by non-NTP public providers","","pub_new_dx","pub_new_dx"
"Is national guidance in place that indicates the use of Xpert MTB/RIF as the initial diagnostic test for the diagnosis of TB in children suspected of having TB?","","xpert_in_guide_children","xpert_in_guide_children"
"Is national guidance in place that indicates the use of Xpert MTB/RIF as the initial diagnostic test for the diagnosis of extrapulmonary TB using selected specimens?","","xpert_in_guide_eptb","xpert_in_guide_eptb"
"Is national guidance in place that indicates the use of Xpert MTB/RIF as the initial diagnostic test for the diagnosis of drug-resistant TB among people at risk?","","xpert_in_guide_MDR","xpert_in_guide_MDR"
"Is national guidance in place that indicates the use of Xpert MTB/RIF as the initial diagnostic test for the diagnosis of TB in all people suspected of having TB?","","xpert_in_guide_tb","xpert_in_guide_tb"
"Is national guidance in place that indicates the use of Xpert MTB/RIF as the initial diagnostic test for the diagnosis of TB in people at risk of HIV-associated TB?","","xpert_in_guide_TBHIV","xpert_in_guide_TBHIV"
